A ‘next generation’ vaccine for malaria has shown success in its first human trial. The phase 1 study saw a strong immune response in 10 healthy volunteers. The vaccine was created by genetically engineering the malaria parasite to make it weaker. Scientist removed the three genes needed for it to successfully infect and cause disease in humans. None of the participants developed malaria symptoms, and showed a strong protective antibody response.
Jan 5, 2017
Ala Vaikunthapurramuloo inches closer to $2.5 million; Sarileru Neekevvaru struggles to cross $2 million mark14 hours ago
- Budget 2020: Centre may impose customs duty hike on more than 300 items
- Budget 2020: Check date, time; what can we expect from this year's budget?
- HDFC Bank customers watch out: Crucial services to be affected on Jan. 18
- Sensex, Nifty tumble as SC dismisses Airtel, Vodafone pleas on payment dues
- Another WeWork in making? Softbank backed Oyo Rooms fire 20 percent of workforce